Page last updated: 2024-11-06

cefazedone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cefazedone: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cefazedone : A first-generation cephalosporin antibiotic having [(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl and [(3,5-dichloro-4-oxopyridin-1(4H)-yl)acetamido side-groups located at positions 3 and 7 respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID71736
CHEMBL ID2107636
CHEBI ID131731
SCHEMBL ID49523
MeSH IDM0076063

Synonyms (52)

Synonym
cefazedone (inn)
56187-47-4
D07237
refosporin sodium salt
cefazedone, sodium salt
nsc304118
(6r,7r)-7-[[2-(3,5-dichloro-4-oxo-1-pyridyl)acetyl]amino]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(3,5-dichloro-4-oxo-1(4h)-pyridinyl)acetyl]amino]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-, monosodium salt, (6r-trans)-
refosporin (*sodium salt*)
cefazedone (*sodium salt*)
cefazedone
cefazedona [inn-spanish]
(6r-trans)7-(((3,5-dichloro-4-oxo-1(4h)-pyridinyl)acetyl)amino)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oxy-2-ene-2-carbox ylic acid
cefazedonum [inn-latin]
(6r,7r)-7-(2-(3,5-dichloro-4-oxo-1(4h)-pyridyl)acetamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)-oct-2-ene-2-carboxylic acid
cefazedone [inn:ban]
5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((3,5-dichloro-4-oxo-1(4h)-pyridinyl)acetyl)amino)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-, (6r-trans)-
refosporene
brn 1097746
refosporen
(6r,7r)-7-[[2-(3,5-dichloro-4-oxopyridin-1-yl)acetyl]amino]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
emd-30087
CHEBI:131731
7-{[3,5-dichloro-4-oxopyridin-1(4h)-yl]acetamido}-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid
(6r,7r)-7-[2-(3,5-dichloro-4-oxopyridin-1(4h)-yl)acetamido]-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
cefazedonum
cefazedona
unii-7y86x0d799
7y86x0d799 ,
5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((2-(3,5-dichloro-4-oxo-1(4h)-pyridinyl)acetyl)amino)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-, (6r,7r)-
cefazedone [who-dd]
cefazedone [mi]
cefazedone [inn]
CHEMBL2107636
S4874
SCHEMBL49523
cefazedone acid
DTXSID50204733
cefazedon
Q5057222
HY-121144
(6r,7r)-7-(2-(3,5-dichloro-4-oxopyridin-1(4h)-yl)acetamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
DB13778
CCG-269995
CS-0079538
D95160
A936727
(6r,7r)-7-(2-(3,5-dichloro-4-oxopyridin-1(4h)-yl)acetamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid
AS-75724
gtpl12203
refosporen;cefazedonum
AKOS040759302

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Due to these pharmacokinetic patterns the results of an earlier prospective trial is confirmed that single-shot antibiotics during surgery are useful to reduce postoperative wound sepsis rate after appendectomy."( [Use of preventive intra-operative antibiotic administration in appendectomy. A pharmacokinetic study].
Adamek, L; Mayer, F; Raguse, T; Wolf, R, 1991
)
0.28
" The validated method was successfully applied to the pharmacokinetic study of cefazedone in Chinese healthy volunteers following intravenous (IV) administration of 500, 1000 and 2000mg cefazedone injection."( Determination of cefazedone in human plasma by high performance liquid chromatography-tandem mass spectrometry: Application to a pharmacokinetic study on Chinese volunteers.
Guo, T; Qian, ZY; Tang, W; Wu, D; Xiang, Y; Zheng, H, 2010
)
0.93

Dosage Studied

ExcerptRelevanceReference
"Intravenous injection of cefazodone sodium with 2 g q12 h dosage regimen is used in the treatment of CAP caused by sensitive bacteria, either ƒT > MIC or clinical efficacy shows that such dosing regimen is reasonable."( A Pharmacokinetic and Pharmacodynamic Study on Intravenous Cefazedone Sodium in Patients with Community-acquired Pneumonia.
Gao, L; Hao, FL; Lyu, Y; Wei, MJ; Zhang, P; Zhu, Y, 2015
)
0.66
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antibacterial drugA drug used to treat or prevent bacterial infections.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
cephalosporinA class of beta-lactam antibiotics differing from the penicillins in having a 6-membered, rather than a 5-membered, side ring. Although cephalosporins are among the most commonly used antibiotics in the treatment of routine infections, and their use is increasing over time, they can cause a range of hypersensitivity reactions, from mild, delayed-onset cutaneous reactions to life-threatening anaphylaxis in patients with immunoglobulin E (IgE)-mediated allergy.
semisynthetic derivativeAny organic molecular entity derived from a natural product by partial chemical synthesis.
thiadiazoles
carboxylic acidA carbon oxoacid acid carrying at least one -C(=O)OH group and having the structure RC(=O)OH, where R is any any monovalent functional group. Carboxylic acids are the most common type of organic acid.
4-pyridonesAny pyridone that is pyridin-4-one or its derivatives by substitution of one of more of the hydrogens.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1292433Steady state trough plasma concentration in chronic polyarthritis patient (6 patients) assessed as 4'-hydroxy diclofenac at 75 mg, po bid administered for 6 to 10 months by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1292436Steady state trough plasma concentration in chronic polyarthritis patient (6 patients) assessed as 4',5-dihydroxy diclofenac at 75 mg, po bid administered for 6 to 10 months by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1292432Steady state trough plasma concentration in chronic polyarthritis patient (6 patients) at 75 mg, po bid administered for 6 to 10 months by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1292437Steady state trough plasma concentration in chronic polyarthritis patient (6 patients) assessed as 3'-hydroxy-4'-methoxy diclofenac at 75 mg, po bid administered for 6 to 10 months by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1292435Steady state trough plasma concentration in chronic polyarthritis patient (6 patients) assessed as 3'-hydroxy diclofenac at 75 mg, po bid administered for 6 to 10 months by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1292434Steady state trough plasma concentration in chronic polyarthritis patient (6 patients) assessed as 5-hydroxy diclofenac at 75 mg, po bid administered for 6 to 10 months by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (66.67)18.7374
1990's4 (19.05)18.2507
2000's0 (0.00)29.6817
2010's3 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.62 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.10 (4.65)
Search Engine Demand Index47.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (19.05%)5.53%
Reviews2 (9.52%)6.00%
Case Studies1 (4.76%)4.05%
Observational0 (0.00%)0.25%
Other14 (66.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]